Total Hip Arthroplasty Combined with Proximal Femoral Reconstruction Effectively Treats Severe Hip Deformities: A Novel Osteotomy Technique

Abstract

Objective: Total hip arthroplasty (THA) combined with proximal femoral reconstruction is a novel osteotomy technique developed to address severe hip deformities. There is a paucity of robust clinical and radiological evidence regarding the outcomes of this novel osteotomy technique. This study aimed to evaluate the clinical and radiological outcomes of THA combined with proximal femoral reconstruction during the early follow-up.

Methods: This is a retrospective case series of 63 hips who underwent THA combined with proximal femoral reconstruction at a single institution between January 2020 and July 2023. The mean age of patients was 39.6 ± 12.6 years. The mean follow-up was 25.6 ± 3.8 months. Surgical characteristics and perioperative variables were evaluated to assess the efficacy of this technique. Harris hip score (HHS) was utilized to evaluate hip function. Leg length discrepancy (LLD) was evaluated in X-ray. The incidence of major adverse events including deep vein thrombosis (DVT), osteolysis, nonunion of the osteotomy, intraoperative femoral fracture, and infection was also evaluated. Paired-samples t-test was used to compare preoperative and postoperative HHS and LLD.

Results: The mean operative time was 125.1 min. The mean size of the acetabular components used was 45.2 mm, and the stem size was 7.5. The primary friction interface was ceramic-on-ceramic, accounting for 92.1% of cases. The average length of hospital stay was 8.5 days. The mean cost of treatment was 46,296.0 Yuan. There was a significant improvement in postoperative HHS (p < 0.001) and LLD (p < 0.001) compared to preoperative values. The incidence of deep venous thrombosis was 4.8%; osteolysis rates for the cup and stem were 4.8% and 6.4%, respectively. The non-union and dislocation rates were 1.6% and 3.2%, respectively. There was no incidence of postoperative infection.

Conclusion: The novel osteotomy surgical procedure yields reliable and impressive clinical and radiological outcomes, with minimal complications. We advocate for its use in complex primary THA cases involving severe proximal femoral deformities.

Keywords

Osteotomy / Proximal femoral deformities / Proximal femoral reconstruction / Total hip arthroplasty

References

[1] Learmonth ID, Young C, Rorabeck C. The operation of the century: total hip replacement. Lancet. 2007; 370(9597): 1508–1519.

[2] Lychagin AV, Cherepanov VG, Petrov PI, Vyazankin IA, Brkich GE. Pre-surgery planning of lower limbs major joints arthroplasty. Open Access Maced J Med Sci. 2019; 7(17): 2838–2843.

[3] Okafor L, Chen AF. Patient satisfaction and total hip arthroplasty: a review. Arthroplasty. 2019; 1(1): 6.

[4] Goodman SM, Mehta BY, Kahlenberg CA, Krell EC, Nguyen J, Finik J, et al. Assessment of a satisfaction measure for use after primary Total joint arthroplasty. J Arthroplasty. 2020; 35(7): 1792–1799.

[5] Yang Y, Zuo J, Liu T, Xiao J, Liu S, Gao Z. Morphological analysis of true acetabulum in hip dysplasia (Crowe classes I-IV) via 3-D implantation simulation. J Bone Jt Surg Am. 2017; 99(17): e92.

[6] Takaoka Y, Goto K, Kuroda Y, Kawai T, Okuzu Y, Matsuda S. Assessment of the damage to hip abductor muscles in primary Total hip arthroplasty with a minimally invasive anterolateral approach with or without trochanteric Flip osteotomy. J Arthroplasty. 2023; 38(6): 1082–1088.

[7] Masson JB, Foissey C, Bertani A, Pibarot V, Rongieras F. Transverse subtrochanteric shortening osteotomy with double tension-band fixation during THA for Crowe III-IV developmental dysplasia: 12-year outcomes. Orthop Traumatol Surg Res. 2023; 109: 103684.

[8] Pan Y, Chen Y. Greater trochanteric osteotomy and subtrochanteric osteotomy in primary/revision total hip arthroplasty. Front Surg. 2023; 10: 1103689.

[9] Liu S, Zuo J, Li Z, Yang Y, Liu T, Xiao J, et al. Study of three-dimensional morphology of the proximal femur in developmental adult dysplasia of the hip suggests that the on-shelf modular prosthesis may not be an ideal choice for patients with Crowe type IV hips. Int Orthop. 2017; 41(4): 707–713.

[10] Chen M, Luo Z, Zhu C, Wu K, Zhang X, Shang X. A reliable femoral osteotomy in Total hip arthroplasty for Hartofilakidis type C developmental dysplasia of the hip: proximal femoral reconstruction. J Arthroplasty. 2019; 34(6): 1162–1167.

[11] World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Jama. 2013; 310(20): 2191–2194.

[12] Götz J, Maderbacher G, Leiss F, Zeman F, Meyer M, Reinhard J, et al. Better early outcome with enhanced recovery total hip arthroplasty (ERAS-THA) versus conventional setup in randomized clinical trial (RCT). Arch Orthop Trauma Surg. 2023; 144: 439–450.

[13] Gruen TA, McNeice GM, Amstutz HC. “modes of failure” of cemented stem-type femoral components: a radiographic analysis of loosening. Clin Orthop Relat Res. 1979; 141: 17–27.

[14] DeLee JG, Charnley J. Radiological demarcation of cemented sockets in total hip replacement. Clin Orthop Relat Res. 1976; 121: 20–32.

[15] Sayed-Noor AS, Hugo A, Sjödén GO, Wretenberg P. Leg length discrepancy in total hip arthroplasty: comparison of two methods of measurement. Int Orthop. 2009; 33(5): 1189–1193.

[16] Jawad MU, Scully SP. In brief: Crowe’s classification: arthroplasty in developmental dysplasia of the hip. Clin Orthop Relat Res. 2011; 469(1): 306–308.

[17] Sponseller PD, McBeath AA. Subtrochanteric osteotomy with intramedullary fixation for arthroplasty of the dysplastic hip: A case report. J Arthroplasty. 1988; 3(4): 351–354.

[18] Wang D, Li LL, Wang HY, Pei FX, Zhou ZK. Long-term results of Cementless Total hip arthroplasty with subtrochanteric shortening osteotomy in Crowe type IV developmental dysplasia. J Arthroplasty. 2017; 32(4): 1211–1219.

[19] Atlihan D, Yildirim C, Muratoglu OG, Muslu DC, Tokgözoğlu M, Bayir D, et al. An oblique osteotomy is better for subtrochanteric shortening in total hip arthroplasty for high hip dislocation: a mechanical comparison of four techniques. Hip Int. 2022; 32(3): 345–352.

[20] Li X, Lu Y, Sun J, Lin X, Tang T. Treatment of Crowe type-IV hip dysplasia using Cementless Total hip arthroplasty and double Chevron subtrochanteric shortening osteotomy: a 5-to 10-year follow-up study. J Arthroplasty. 2017; 32(2): 475–479.

[21] Charnley J, Ferreiraade S. Transplantation of the greater trochanter in arthroplasty of the hip. J Bone Jt Surg Br. 1964; 46: 191–197.

[22] Glassman AH, Engh CA, Bobyn JD. A technique of extensile exposure for total hip arthroplasty. J Arthroplasty. 1987; 2(1): 11–21.

[23] Li C, Zhang C, Zhang M, Ding Y. Comparison of transverse and modified subtrochanteric femoral shortening osteotomy in total hip arthroplasty for developmental dysplasia of hip: a meta-analysis. BMC Musculoskelet Disord. 2014; 15: 331.

[24] Fahlbusch H, Budin M, Volk A, von Rehlingen Prinz F, Linke P, Citak M, et al. Long-term outcomes of total hip arthroplasty in patients with developmental dysplasia of the hip: a minimum 21-year follow-up. Arch Orthop Trauma Surg. 2023; 143(11): 6609–6616.

[25] Ollivier M, Abdel MP, Krych AJ, Trousdale RT, Berry DJ. Long-term results of Total hip arthroplasty with shortening subtrochanteric osteotomy in Crowe IV developmental dysplasia. J Arthroplasty. 2016; 31(8): 1756–1760.

[26] Sun C, Zhang Y, Li LT, Ding H, Guo T, Zhao JN. Long-term outcomes of Total hip arthroplasty with transverse subtrochanteric shortening osteotomy and modular stem in Crowe IV developmental dysplasia. J Arthroplasty. 2021; 36(2): 630–635.

[27] Leong G, Wilson J, Charlett A. Duration of operation as a risk factor for surgical site infection: comparison of English and US data. J Hosp Infect. 2006; 63(3): 255–262.

[28] Liu T, Wang S, Huang G, Wang W. Treatment of Crowe IV developmental dysplasia of the hip with cementless total hip arthroplasty and shortening subtrochanteric osteotomy. J Int Med Res. 2019; 47(7): 3223–3233.

[29] Necas L, Hrubina M, Melisik M, Cibula Z, Chmurny M, Daniel M, et al. Cementless hip arthroplasty and transverse shortening femoral osteotomy with the S-ROM stem for Crowe type IV developmental dysplasia. Eur J Orthop Surg Traumatol. 2019; 29(5): 1025–1033.

[30] Zeng WN, Liu JL, Wang FY, Zhang X, Fan HQ, Chen GX, et al. Total hip arthroplasty for patients with Crowe type IV developmental dysplasia of the hip: ten years results. Int J Surg. 2017; 42: 17–21.

[31] Grappiolo G, La Camera F, Della Rocca A, Mazziotta G, Santoro G, Loppini M. Total hip arthroplasty with a monoblock conical stem and subtrochanteric transverse shortening osteotomy in Crowe type IV dysplastic hips. Int Orthop. 2019; 43(1): 77–83.

RIGHTS & PERMISSIONS

2024 The Author(s). Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.